New eczema balm trial: can it match the gold standard?
NCT ID NCT07358000
Summary
This study compares two moisturizing balms for treating mild to moderate eczema (atopic dermatitis) in children and adults. Researchers want to see if a new balm called Relipid+ works as well as the commonly prescribed Lipikar balm. The trial will measure skin improvement, itching, quality of life, and steroid cream use over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Caen Normandie
Caen, Normandy, France
Conditions
Explore the condition pages connected to this study.